Photograph of physician looking at x-rayThe Alliance of Speciality Medicine
QUICK INFORMATION FOR:PolicymakersPhysiciansPatientsMedia

NEWS & UPDATES

Alliance Comments on the 2019 Policy and Technical Changes to the Medicare Advantage and Part D Prescription Drug Program Proposed Rule

01/16/2018

The Alliance of Specialty Medicine urged CMS Administrator Seema Verma to take significant steps to ensure beneficiary access to specialty medicine and the providers that deliver specialty care through a series of recommendations in comments on the 2019 Policy and Technical Changes to the Medicare Advantage (MA) and Part D Prescription Drug Program proposed rule. The specialty coalition urged CMS to improve the Quality Rating System by establishing a number of new stars measures and implement a physicians’ experience survey with the aim of creating meaningful quality improvement incentives and differentiating plans based on the quality of specialty medical care. The Alliance also urged CMS to make a number of requirements to reduce the burden on physicians associated with MA medical record requests and modify its “Preclusion List” criteria, ensuring they are rigorous, objective and subject to notice-and-comment rulemaking. Finally, the Alliance responded to CMS’ request for information regarding the application of manufacturer rebates and pharmacy price concessions to drug prices at the point of sale, supporting a mandatory pass-through of price concessions and urging the agency to move forward with implementing such a policy.

Click here to access the letter.

 

 

 

Home | About the Alliance | Contact Us | Legal Notice | Site Map
   
  © 2012 The Alliance of Specialty Medicine